Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA

Martinon, Frédéric, Krishnan, Sivadasan, Lenzen, Gerlinde, Magné, Rémy, Gomard, Elisabeth, Guillet, Jean‐Gérard, Lévy, Jean‐Paul, Meulien, Pierre·1993·European Journal of Immunology
DOI 10.1002/eji.1830230749

Cited by (472)

Items 301–400 of 472

  1. La nueva generación de vacunas de ARN mensajero (ARNm) frente a la gripe
    Jordi Reina · 2021 · Enfermedades Infecciosas y Microbiología Clínica
  2. Emerging trends of research on mRNA vaccines: A co-citation analysis
    Juan Chen, Ting Zhang, Yan Zhen Lu, Xiaoyi Yang, Zhaolian Ouyang · 2022 · Human Vaccines & Immunotherapeutics
  3. The mRNA Vaccine Heralds a New Era in Vaccinology
    Ketaki Shinde, Sonam Bendre, Niraj Kale, Suhit Gilda · 2022 · Asian Journal of Pharmacy and Technology
  4. The new generation of messenger RNA (mRNA) vaccines against influenza
    Jordi Reina · 2022 · Enfermedades infecciosas y microbiologia clinica (English ed )
  5. Virus-specific cytotoxic T-lymphocyte activity elicited by coimmunization with human immunodeficiency virus type 1 genes regulated by the bacteriophage T7 promoter and T7 RNA polymerase protein
    Mark Selby, Barbara Doe, Christopher M. Walker · 1997 · Journal of Virology
  6. Measuring the Adjuvant Activity of RNA Vaccines
    Norbert Pardi, Drew Weissman · 2016 · Methods in molecular biology
  7. mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses
    Janan Shoja Doost, Fatemeh Fazel, Nitish Boodhoo, Shayan Sharif · 2024 · Viruses
  8. Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2
    Jiin H. Felgner, Jenny E. Hernandez‐Davies, Erwin Strahsburger, Emily K. Silzel, Rie Nakajima, Aarti Jain, Jacob Laster, Jui-Lin Chiang, Ya-Li Tsai, Philip Louis Felgner et al. · 2025 · npj Vaccines
  9. Erythrocytes enhance the immunogenicity of oral vaccination with gamma irradiated influenza virus: increasing the dose of irradiation results in a significant diminution of lung IgA response
    Brett Andrew Lidbury, Terry V. Grissell, Philip J.H. Sizer, Gerald Pang, Robert L Clancy, Allan W. Cripp · 1997 · Vaccine
  10. How the initial discovery of modified RNA enabled evasion of innate immune responses and facilitated the development of RNA therapeutics
    Mouldy Sioud · 2023 · Scandinavian Journal of Immunology
  11. An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease
    Jianglong Li, Haiyan Long, Shaoyi Chen, Zhendong Zhang, Shuang Li, Qi Liu, Jun Liu, Jiaru Cai, Liping Luo, Yucai Peng · 2025 · Vaccines
  12. Overview of Current Immunotherapies Targeting Mutated KRAS Cancers
    Winfrey Pui Yee Hoo, Pui Yan Siak, Lionel Lian Aun In · 2019 · Current Topics in Medicinal Chemistry
  13. Messenger RNA Vaccines
    Jochen Probst, Mariola Fotin‐Mleczek, Thomas Schlake, Andreas Theß, Thomas Kramps, Karl‐Josef Kallen · 2011 · Springer eBooks
  14. Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines
    Sergio Gil-Manso, Diego Carbonell, Verónica Astrid Pérez-Fernández, Rocío López-Esteban, Roberto Alonso, Patricia Muñóz, Jordi Ochando, Ignacio Sánchez-Arcilla, José María Bellón, Rafael Correa‐Rocha et al. · 2022 · Biomedicines
  15. Progress in vaccine development for infectious diseases—a Keystone Symposia report
    Jennifer Cable, Barney S. Graham, Richard A. Koup, Robert A. Seder, Katalin Karikó, Norbert Pardi, Dan H. Barouch, Bhawna Sharma, Susanne Rauch, Raffael Nachbagauer et al. · 2023 · Annals of the New York Academy of Sciences
  16. Bionanotechnology and bioMEMS (BNM): state-of-the-art applications, opportunities, and challenges
    Jeffrey T. Borenstein, Gerard Cummins, Abhishek Dutta, Eyad M. Hamad, Michael Pycraft Hughes, Xingyu Jiang, Hyowon Lee, Kin Fong Lei, Xiaowu Shirley Tang, Yuanjin Zheng et al. · 2023 · Lab on a Chip
  17. COVID-19, des vaccins à la vitesse de l’éclair
    Yanis Feraoun, Pauline Maisonnasse, Roger Le Grand, Anne‐Sophie Beignon · 2021 · médecine/sciences
  18. Evidence for the involvement of the RNA-dependent protein kinase (PKR) in the induction of human cytotoxic T lymphocytes against a synthetic peptide of HIV-1 by regulatory RNA
    Fernando Luiz De Lucca, Valéria Soraya Farias Sales, Liliana R. Souza, Maria Angélica Ehara Watanabe · 2002 · Molecular and Cellular Biochemistry
  19. Nanopore-Based Electroporation Enables High-Efficiency, Rapid RNA-Mediated Reprogramming of Primary Fibroblasts into Human iPSCs
    Xiangyu Ren, Yi Weng, Ziwei Zhang, Guangjin Pan, Chaobo Li, Yuhong Cao · 2025 · Nano Letters
  20. RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens
    Naga Suresh Kola, Dhruv Patel, Aneesh Thakur · 2024 · Methods in molecular biology
  21. Path to Success and Future Impact of Nucleic Acid Vaccines: DNA and mRNA
    Jeffrey B. Ulmer, Margaret A. Liu · 2021 · Molecular Frontiers Journal
  22. Vaccines: An overview
    Santiago M. C. Lopez, Alice I. Sato, Archana Chatterjee · 2023 · Elsevier eBooks
  23. Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history
    Steve Pascolo · 2023 · European Journal of Immunology
  24. mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond
    Satyendra Prakash · 2023 · European Journal of Drug Metabolism and Pharmacokinetics
  25. Analyses of the 2023 Nobel Prize in Physiology or Medicine: Nucleoside Base Modifications and Effective mRNA Vaccines
    Elizabeth Alison Sterner · 2023 · Science & Technology Libraries
  26. Nucleic Acid Delivery Nanotechnologies for In Vivo Cell Programming
    Hannia V. Balcorta, Veronica Guerrero, Deepali Bisht, Wilson Poon · 2024 · ACS Applied Bio Materials
  27. Effect of the calcium phosphate-mediated RNA uptake on the transfer of cellular immunity of a synthetic peptide of HIV-1 to human lymphocytes by exogenous RNA
    Fernando Luiz De Lucca, Fahim Miguel Sawan, Maria Angélica Ehara Watanabe, Liliana R. de Souza · 2001 · Molecular and Cellular Biochemistry
  28. Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine
    Jean‐Pierre Couty, Anne‐Marie Crain‐Denoyelle, Sylvie Gerbaud, Marilyne Labasque, Carmen Marchiol, DIDIER FRADELIZI, Sarah Boudaly, Catherine Guettier, Marco Vignuzzi, Sylvie van der Werf et al. · 2008 · Cancer Immunology Immunotherapy
  29. RNA Vaccination Therapy: Advances in an Emerging Field
    Sebastian Kreiter, Mustafa Diken, Steve Pascolo, Smita K. Nair, Kris Thielemans, Andrew J. Geall · 2016 · Journal of Immunology Research
  30. The rise of mRNA therapeutic vaccines
    Jinlu Du, Ziling Fan, Jiangming Huang, Zhengyuan Li, Haitao Hu, Yanxia Li · 2025 · RSC Pharmaceutics
  31. The Application of Single-Cell Technologies for Vaccine Development Against Viral Infections
    Hong Nhi Nguyen, Isabel Vanderzee, Fei Wen · 2025 · Vaccines
  32. Enzymatic Synthesis of Base-Modified Nucleic Acids
    Marcel Hollenstein · 2023 · Springer eBooks
  33. Prix Nobel de physiologie ou médecine 2023 : Katalin Karikó et Drew Weissman
    Marie‐Caroline Dieu‐Nosjean, Jean‐Luc Teillaud · 2024 · médecine/sciences
  34. Nucleic acid delivery for pathology treatment: RNA tissue delivery
    Silvia Scalabrin, Stefano Cagnin · 2025 · Molecular Therapy — Nucleic Acids
  35. Vaccine Design in the 21st Century
    Matthew J. Bottomley, Rino Rappuoli, Oretta Finco · 2016 · Elsevier eBooks
  36. Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review
    Christine M. Akamine, Hana M. El Sahly · 2021 · Translational research
  37. Production and delivery of recombinant subunit vaccines
    Christin Andersson · 2000 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  38. Unraveling the potential: mRNA therapeutics in oncology
    Karol Gawalski, Weronika Przybyszewska, Jaromir Hunia, Alicja Gawalska, Aleksandra Rymarz · 2025 · Frontiers in Oncology
  39. RNA vaccines for cancer: revolutionizing immunization strategies
    Di Huang, Jiahui Zhang, Xin Zeng, Yin Zhang, Erwei Song · 2025 · Trends in cancer
  40. Health Technology Assessment of mRNA Vaccines: Clinical, Economic, and Public Health Implications
    Giovanni Genovese, Caterina Elisabetta Rizzo, Cristina Genovese · 2025 · Vaccines
  41. Insights from Computational Studies of Polymeric Systems for Nucleic Acid Delivery
    Jesse Dylan Ziebarth, Hossain Shadman, Yongmei Wang · 2025 · Molecular Pharmaceutics
  42. Anti-SARS-CoV-2 (COVID-19) vaccination efficacy in patients with severe neuromuscular diseases
    A. Damour, Paul Delalande, Fabrice P. Cordelières, Marie‐Edith Lafon, Muriel Faure, Sandrine Ségovia-Kueny, Caroline Stalens, Stéphane Mathis, Marco Spinazzi, Marie‐Hélène Violleau et al. · 2023 · Revue Neurologique
  43. Introduction to RNA Vaccines Post COVID-19
    Thomas Kramps · 2024 · Methods in molecular biology
  44. STEMIN and YAP5SA, the future of heart repair?
    Nada Bejar, Siyu Xiao, Dinakar Iyer, Azeez Muili, Adeniyi Adeleye, Bradley K. McConnell, Robert John Schwartz · 2024 · Experimental Biology and Medicine
  45. Safety and efficacy of RNA vaccines: State of the art
    A. V. Blagov, Anna A. Bukaeva, Valentin Vladimirovich Makarov, Zanda Bochkaeva · 2021 · Medical Immunology (Russia)
  46. Anti-HIV Vaccines
    Stephen Norley, Thorsten U. Vogel, Reinhard Kurth · 1993 · Drugs
  47. Generation of CTL responses using Kunjin replicon RNA
    Scott M. Ward, Robert W. Tindle, Alexander A. Khromykh, Eric James Gowans · 2003 · Immunology and Cell Biology
  48. DNA-Based Immunization
    Heather L. Davis, Cynthia L. Brazolot Millan · 1999 · Blood cell biochemistry
  49. mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases
    Brandon E. K. Tan, Seng Kong Tham, Chit Laa Poh · 2025 · Viruses
  50. Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications
    Saumya Nishanga Heendeniya, Suxiang Chen, S. H. Bhatti, Qurat ul ain Zahra, Kamal Rahimizadeh, Bal Hari Poudel, Steve Donald Wilton, Rakesh Naduvile Veedu · 2025 · Experimental Biology and Medicine
  51. The Quest for mRNA Vaccines
    Eli Gilboa, David Boczkowski, Smita K. Nair · 2022 · Nucleic Acid Therapeutics
  52. Recruiting Natural Killer T Cells to Improve Vaccination: Lessons from Preclinical and Clinical Studies
    Olivia K. Burn, Nathaniel Dasyam, Ian F. Hermans · 2023 · Critical Reviews™ in Oncogenesis
  53. RNA therapeutics history and future perspectives
    Hong‐Quan Duong, Minh-Cong Hoang, Thi-Hue Nguyen, Van-Lang Ngo, Van-Thu Le · 2024 · Progress in molecular biology and translational science
  54. Critical applications and prospects of RNA modification in mRNA vaccines
    Cong Liu, Jinying Peng, Meiling Zhang, Huifen Xiang, Chengqi Yi · 2024 · Chinese Science Bulletin (Chinese Version)
  55. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine
    Shanti Pather, Nicola Charpentier, Frank van den Ouweland, Ruben Rizzi, Andrew Finlayson, Nadine C. Salisch, Alexander Muik, Claudia Lindemann, Ruzwana Khanim, Sultan Abdul-Jawad et al. · 2024 · Vaccine
  56. Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines
    Ruiying Wu, Huixin Li, Ziqin Li, Kai Hao, Huayu Tian · 2025 · Journal of Materials Chemistry B
  57. RNA Vaccines: The Evolution, Applications, and the Challenges Ahead
    Ishani Banerji, Shreya Bhattacharjee, Kamalika Mukherjee, Suvendra N. Bhattacharyya · 2023 · Springer eBooks
  58. Strategies for HIV-1 suppression through key genes and cell therapy
    Alyona V. Sorokina, Elizaveta Anchakova, Erdem Bairovich Dashinimaev · 2023 · Frontiers in Medicine
  59. RNA therapeutics for regenerative medicine
    Yen Vy Nguyen Thi, Anh Dao Ngo, Dinh‐Toi Chu, Sheng-Che Lin, Chia‐Ching Wu · 2024 · Progress in molecular biology and translational science
  60. mRNA Vaccination and Personalized Cancer Therapy
    Sebastian Kreiter, Mustafa Diken, Uğur Şahin · 2014 · Springer eBooks
  61. The Characteristics of RNA Vaccine; its Strengths and Weaknesses
    Hyo‐Jung Park, Hae Li Ko, Seo-Yeon Jung, Han-Byeol Jo, Jae‐Hwan Nam · 2016 · Journal of Bacteriology and Virology
  62. Studies on the IgA‐independent immunological responses in mice to influenza virus challenge after oral vaccination with irradiated whole virus and an erythrocyte complex
    Brett Andrew Lidbury, Terrence V Grissell, Philip J.H. Sizer, Robert L Clancy, Allan W. Cripps · 2000 · Immunology and Cell Biology
  63. “Wrapped Up” Vaccines in the Context of HIV-1 Immunotherapy
    Winni De, Charlotte Pollard, Guido L. Vanham, Joanna Rejm · 2012 · InTech eBooks
  64. Gene Therapy and Cardiovascular Diseases
    Dongchao Lu, Sarah Cushman, Thomas Thum, Christian Bär · 2022 · Advances in experimental medicine and biology
  65. Advances in cancer gene therapy
    Guadalupe Bilbao, Juan Luis Contreras, David T. Curiel · 1999 · Expert Opinion on Therapeutic Patents
  66. A Historical Overview on mRNA Vaccine Development
    Rein Verbeke, Miffy H. Y. Cheng, Pieter R. Cullis · 2024 · Wiley eBooks
  67. Vaccination with Polynucleotides: A Novel Means of Generating Immunity
    Jeffrey B. Ulmer, John Donnelly, Margaret A. Liu · 1994 · Springer eBooks
  68. RNA therapeutics: Molecular mechanisms, and potential clinical translations
    Tiep Tien Nguyen, Yen-Vy Nguyen Thi, Dinh‐Toi Chu · 2024 · Progress in molecular biology and translational science
  69. Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus
    Buyani Ndlovu, Albertha R. van Zyl, D. J. Verwoerd, Edward P. Rybicki, Inga Isabel Hitzeroth · 2025 · Vaccines
  70. Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatment
    Christopher A. P. Batho, James E. Hudson, Catherine H. Wilson · 2025 · Biochemical Society Transactions
  71. mRNA vaccines transform personalized lung cancer treatment
    Kaiqi Wei, Zitong Wan, Miaomiao Wen, Shaowei Xin, Yinxi Zhou, Jun Chao Wei, Jianfei Zhu, Chengbin Tang, Yanlu Xiong, Tao Jiang et al. · 2026 · Frontiers in Immunology
  72. The Evolving Landscape of mRNA Therapeutics: From Molecular Design and Advanced Delivery Systems to Clinical Translation and Future Vistas
    Ebrahim Sadaqa, Adam Arditya Fajriawan, Sjaikhurrizal El Muttaqien · 2026 · Biointerface Research in Applied Chemistry
  73. ADVANCES IN THE DEVELOPMENT OF MRNA-VACCINES
    N. S. Golyak, В. М. Царенков, Olga A. Sushinskaya, O. G. Sechko, S. S. Malchenkova · 2025 · Vestnik Farmacii
  74. Recent advances in LNP-mRNA vaccines
    Benjamin J. Redenti, Yichen Zhong, Changyue Yu, Yizhou Dong · 2026 · Colloids and Surfaces B Biointerfaces
  75. Optimizing mouse models for mRNA vaccines: addressing dose translation challenges
    Zi Wei Chang, Yong Jie Tan, Yiyu Liao, Yun Shan Goh, Syed Ridwan Kabir, Yuqian Wang, Pei Xiang Hor, Chiew Yee Loh, Yuling Huang, Bei Wang et al. · 2026 · Scientific Reports
  76. Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
    Randall N. Hyer · 2022 · The Cancer Journal
  77. Enzymatic Synthesis of Base-Modified Nucleic Acids
    Marcel Hollenstein · 2023 · Springer eBooks
  78. Applications of advances in mRNA-based platforms as therapeutics and diagnostics in reproductive technologies
    Wjdan S. Bafleh, Haia M. R. Abdulsamad, Sally M. Al-Qaraghuli, Riwa Y. El Khatib, Rawdah Taha Elbahrawi, Azhar Mohamud Abdukadir, Shaima M. Alsawae, Zakia Dimassi, Hamdan Hamdan, Junaid Kashir · 2023 · Frontiers in Cell and Developmental Biology
  79. A Design of mRNA-Based COVID-19 Vaccine Through Fuzzy Neural Network
    Farnaz Sabahi · 2023 · IEEE Transactions on Computational Biology and Bioinformatics
  80. A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab
    Natalia Teresa Jarzębska, Julia Frei, Mark Mellett, Thomas M. Kündig, Steve Pascolo, Andreas Michael Reichmuth · 2024 · Methods in molecular biology
  81. Identifying and reducing risks of neurological complications associated with vaccination
    Lahiru Handunnetthi, Maheshi Ramasamy, Lance C. W. Turtle, David P J Hunt · 2024 · Nature Reviews Neurology
  82. Antitumor mRNA vaccines based on neoantigens
    Ekaterina V. Starostina, L. F. Nizolenko, Л. И. Карпенко, A. A. Ilyichev · 2025 · Siberian Journal of Oncology
  83. The application of modified mRNA in the treatment and prospective vaccine development for cardiovascular diseases
    Yan Zou, Jennifer Ming Jen Wong, Jinzhong Lin, Yuxiang Dai · 2025 · Cardiology Plus
  84. RNA-based vaccines against SARS-CoV-2
    Sergio Rosales‐Mendoza, Alejandra Wong-Arce, Lourdes Betancourt-Mendiola · 2021 · Elsevier eBooks
  85. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Epidemiology and Vaccinology in Nigeria
    Ridwan Olamilekan Adesola, Oluwatobi Emmanuel Oladele, Ahmed Oluwasegun Tajudeen, Oluwatobi Ogundepo, M. Dinesh · 2021 · International Journal of Travel Medicine and Global Health
  86. COVID ‐19 mRNA vaccines and myopericarditis
    Sonali Rukshana Gnanenthiran, Sandhya Limaye · 2022 · Internal Medicine Journal
  87. Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
    Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, Déborah Carolina Carvalho dos Anjos, Miriam Leandro Dorta, João Victor Batalha-Carvalho, Ana Maria Moro, Pedro Roosevelt Torres Romão, Menira Borges Lima Dias Souza, Fabíola Souza Fiaccadori et al. · 2023 · Vaccines
  88. Personalized vaccines, novel vaccination technologies, and future prospects
    Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, Sajeev Sridhar, Abhishek Prasad, Shreya Khandelwal, Santosh Baniya, Carlos Alberto Calvario Miguela, Piyush Gondaliya · 2024 · Elsevier eBooks
  89. mRNA Vaccines to Protect Against Diseases
    Sunil Thomas, Ann Abraham · 2021 · Methods in molecular biology
  90. Development and evaluation of DNA vaccines in chickens against a wild bird H6N2 avian influenza virus from Western Australia
    Songhua Shan · 2010 · Murdoch University Research Portal
  91. Genetic Vaccination with Plasmid Vectors
    Jörg Reimann, Marcin Kwissa, Reinhold Schirmbeck · 2001
  92. Heat shock proteins as vaccine adjuvants
    Khaleda Rahman Qazi · 2005 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  93. Vaccine development strategies applied to the Plasmodium falciparum malaria antigen 332
    Nina-Maria Vasconcelos · 2006 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  94. Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems
    Dalton W. Staller, Flobater I. Gawargi, Sanjali S. Panigrahi, Paras Kumar Mishra, Ram I. Mahato · 2025 · Pharmacological Reviews
  95. The Role of Long Non-Coding RNAs in Skeletal Muscle Pathophysiology: A Therapeutic Perspective
    Silvia Scalabrin, Sanaz Kavoosi, Stefano Cagnin · 2025 · Genetics.
  96. The mRNA vaccine contributors: Assessing their impact through a mainstream lens
    Mei Hsiu‐Ching Ho, John S. Liu, Weiping Wang, Thomas Chiang Chuang · 2025 · Technological Forecasting and Social Change
  97. RNA Therapeutics: Bridging Discovery and Clinical Implementation
    Mouldy Sioud · 2025 · Methods in molecular biology
  98. Neoantigen mRNA Cancer Vaccines: How Deep Learning Is Advancing Design and Breaking Barriers
    Saba Ismail, Khaled Barakat · 2025 · IntechOpen eBooks
  99. Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses
    Bin Zhang, Yaoming Liu, Tao Chen, Jintao Lai, Sen Liu, Xiaoqing Liu, Yiqiang Zhu, Haiyue Rao, Haojie Peng, Xiancai Ma · 2025 · Vaccines
  100. Structural evolution of ionizable lipids for nucleic acid delivery
    Lulu Xue, Melgious Jin Yan Ang, Kelsey L. Swingle, Emily Fitzgerald, Ori Z. Chalom, Ning Gu, Michael J. Mitchell · 2026 · Nature Reviews Chemistry